Patent ID: 8399493

Claim:
A method for treating or controlling schizophrenia in a mammal comprising administering to a patient in need thereof a compound according to the Formula (I), a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof or an N-oxide form thereof, wherein: M 1 is a phenyl group having at least one halo group; and M 2 is a phenyl group substituted with at least one substituent selected from the group consisting of (C 1 -C 6 )alkyloxy, pyridinyl-(C 1 -C 6 )alkyloxy, morpholinyl-(C 1 -C 6 )alkyloxy, pyrrolidinyl-(C 1 -C 6 )alkyloxy optionally substituted with oxo, isoxazolyl-(C 1 -C 6 )alkyloxy, imidazolyl-(C 1 -C 6 )alkyloxy, tetrazolyl-(C 1 -C 6 )alkyloxy or thiazolyl-(C 1 -C 6 )alkyloxy, wherein the isoxazolyl, imidazolyl, tetrazolyl or thiazolyl rings may be optionally substituted with methyl.